{
    "doi": "https://doi.org/10.1182/blood-2021-153028",
    "article_title": "CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program ",
    "article_date": "November 5, 2021",
    "session_type": "615.Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies",
    "abstract_text": "Introduction: The outcome of patients with acute myeloid leukemia (AML) secondary to myelodisplastic syndrome (MDS) or therapy-related (t-AML) receiving conventional treatment and allogeneic stem cell transplantation consolidation (HSCT) is poor. CPX-351 is a new drug composed by liposomal encapsulated cytarabine and daunorubicin, at a fixed molecular ratio of 5:1. It showed superior results, compared to standard 3+7 induction, in a phase III trial (Lancet et al, JCO 2018) in patients affected by t-AML or AML with myelodisplasia-related changes and it is now commercially available for secondary AML (sAML). We recently published results from CPX-351 Italian Named (Compassionate) Use Program (CUP) which enrolled 73 elderly sAML patients (Guolo et al, Blood Cancer J. 2020) showing that CPX-351 is an effective induction regimen for high risk AML patients treated with a curative aim. With a limited follow up, our data suggested the good activity and tolerability of CPX-351. Good quality remissions with acceptable toxicity in the majority of patients was achieved and CPX-351 increased the feasibility of HSCT in a poor risk AML cohort. Scarce data are available on long term outcome of high risk patients receiving CPX-351 in the real life setting. Here we report the results from the extended follow up analysis of the Italian CUP. Results: Seventy three patients were enrolled between December 2018 and June 2019 in a compassionate use program (CUP) in 33 Italian Hematology Centers. Data collection began on July 2019 and included 71/73 patients (97.2%), enrolled in 31 Centers. As previously reported, median age was 65.5 years (52-79). Sixty-two (88%) patients had at least one relevant comorbidity upon enrollment. Six patients (9%) presented with ECOG 3-4 upon enrollment. With a median follow up of 22 months, median overall survival (OS) was 13 months (21.2 - 22.8 95% IC). Two-years OS was 28.6% in the whole cohort. In order to confirm the positive impact of HSCT in first complete remission (CR) and the correlation with the other variables, a landmark model was applied, including only patients alive and in CR at day 90. In landmark analysis, HSCT performed in first CR after CPX-351 was the only significant predictor of longer survival: median OS was not reached for patients transplanted in first CR Vs 12 months for patients who did not undergo HSCT, p < 0.05, Figure1). Two-year OS for patients who received HSCT was 57.6% vs 15.8% for patients who did not undergo HSCT. Conclusions: Results from the extended follow up of Italian CPX-351 CUP confirm the good activity CPX-351 in such a difficult cohort as sAML. Two-year OS for transplanted patients is high despite the high median age, the high frequency of severe comorbidities in this real life cohort of patients and the high frequency of high risk AML. On the contrary, non-transplanted patients show a poor outcome, thus confirming that CPX-351 induction as an optimal bridge to transplant induction therapy. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures Galimberti:  Incyte: Speakers Bureau; AbbVie, Janssen: Honoraria, Other: Travel grants. Marco:  Insight,: Consultancy; Jazz: Consultancy; Janssen: Consultancy. Fracchiolla:  Amgen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pfizer: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Abbvie: Honoraria, Membership on an entity's Board of Directors or advisory committees; Gilead: Honoraria, Speakers Bureau. Tafuri:  Roche: Research Funding; Novartis: Research Funding; Celgene: Research Funding. Rossi:  Novartis: Membership on an entity's Board of Directors or advisory committees; Jazz: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; Daiichi Sankyo: Consultancy, Honoraria; Celgene: Membership on an entity's Board of Directors or advisory committees; Astellas: Membership on an entity's Board of Directors or advisory committees; Amgen: Honoraria, Membership on an entity's Board of Directors or advisory committees; Alexion: Membership on an entity's Board of Directors or advisory committees; Abbvie: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Sanofi: Honoraria; Takeda: Membership on an entity's Board of Directors or advisory committees. Pagano:  Gilead Science, MSD, Pfizer, Basilea, Janssen, Novartis, Jazz Pharmaceutical, Cidara: Membership on an entity's Board of Directors or advisory committees; Menarini: Consultancy; Gilead Sciences, MSD, Pfizer Pharmaceuticals, Astellas Pharma: Speakers Bureau.",
    "author_names": [
        "Paola Minetto",
        "Fabio Guolo",
        "Luana Fianchi",
        "Marino Clavio",
        "Michele Gottardi",
        "Mauro Endri",
        "Sara Galimberti",
        "Giuliana Rizzuto",
        "Margherita Scium\u00e9",
        "Michela Rondoni",
        "Giambattista Bertani",
        "Michelina Dargenio",
        "Atto Billio",
        "Barbara Scappini",
        "Patrizia Zappasodi",
        "Anna Maria Scattolin",
        "Francesco Grimaldi",
        "Giuseppe Pietrantuono",
        "Pellegrino Musto",
        "Cerrano Marco",
        "Stefano D'Ardia",
        "Ernesta Audisio",
        "Alessandro Cignetti",
        "Crescenza Pasciolla",
        "Francesca Pavesi",
        "Anna Candoni",
        "Carmela Gurrieri",
        "Monica Morselli",
        "Caterina Alati",
        "Nicola S Fracchiolla",
        "Giovanni Rossi",
        "Manuela Caizzi",
        "Fabrizio Carnevale Schianca",
        "Michele Cea",
        "Agostino Tafuri",
        "Giuseppe Rossi",
        "Felicetto Ferrara",
        "Livio Pagano",
        "Roberto Massimo Lemoli"
    ],
    "author_dict_list": [
        {
            "author_name": "Paola Minetto",
            "author_affiliations": [
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Fabio Guolo",
            "author_affiliations": [
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy",
                "IRCCS Ospedale Policlinico San Martino, Genoa, Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luana Fianchi",
            "author_affiliations": [
                "Hematology, Sacred Hearth Catholic University, Agostino Gemelli Hospital, Rome, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marino Clavio",
            "author_affiliations": [
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Gottardi",
            "author_affiliations": [
                "OncoHematology, Department of Oncology, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mauro Endri",
            "author_affiliations": [
                "UOC Ematologia - Ospedale Ca' Foncello - Treviso, treviso, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Galimberti",
            "author_affiliations": [
                "University of Pisa, Department of Clinical and Experimental Medicine, Hematology, Pisa, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuliana Rizzuto",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Margherita Scium\u00e9",
            "author_affiliations": [
                "Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michela Rondoni",
            "author_affiliations": [
                "Azienda Unit\u00e0 Sanitaria Locale della Romagna, U.O.C. di Ematologia, Ravenna, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giambattista Bertani",
            "author_affiliations": [
                "ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michelina Dargenio",
            "author_affiliations": [
                "Hematology and Stem Cell Transplantation Unit, Vito Fazzi Hospital, Lecce, Italy, Lecce, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Atto Billio",
            "author_affiliations": [
                "Ematologia e Centro TMO, Ospedale S.Maurizio, Azienda Sanitaria dell'Alto Adige, Bolzano, ITA"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Scappini",
            "author_affiliations": [
                "Hematology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizia Zappasodi",
            "author_affiliations": [
                "Department of Hematology Oncology Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Maria Scattolin",
            "author_affiliations": [
                "Complex Operative Unit of Haematology, dell'Angelo Hospital and Santissimi Giovanni and Paolo Hospital, Venezia Mestre, Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Grimaldi",
            "author_affiliations": [
                "University of Naples Federico II, Naples, Italy, Napoli, ITA"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Pietrantuono",
            "author_affiliations": [
                "IRCCS Centro Oncologico Della Basilicata, Rionero In Vulture, ITA"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pellegrino Musto",
            "author_affiliations": [
                "Hematology and Stem Cell Transplantation Unit - A.O.U. Consorziale Policlinico di Bari, Bari, Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cerrano Marco",
            "author_affiliations": [
                "Division of Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano D'Ardia",
            "author_affiliations": [
                "A.O.U. Citt\u00e0 della Salute e della Scienza, Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2, Torino, Italy"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ernesta Audisio",
            "author_affiliations": [
                "SC Ematologia 2, Dipartmento di Ematologia e Oncologia, AOU Citt\u00e0 della Salute e della Scienza, Torino, Italy"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Cignetti",
            "author_affiliations": [
                "Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Crescenza Pasciolla",
            "author_affiliations": [
                "Istituto Tumori Bari \"Giovanni Paolo\" IRCCS, Bari, Italy"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Pavesi",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute IRCCS, Milano, Italy"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Candoni",
            "author_affiliations": [
                "Division of Hematology and Bone Marrow Transplantation, Clinica Di Ematologia E Unit\u00e0 Di Terapie Cellulari 'carlo Melzi'-Azienda, Udine, Italy"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmela Gurrieri",
            "author_affiliations": [
                "Dipartimento Strutturale Aziendale Medicina, University of Padova, Padua, ITA"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Morselli",
            "author_affiliations": [
                "University of Modena and Reggio Emilia, Modena, ITA"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Alati",
            "author_affiliations": [
                "Division of Hematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicola S Fracchiolla",
            "author_affiliations": [
                "Hematology Unit, FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, Italy"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanni Rossi",
            "author_affiliations": [
                "Hematology, IRCCS \"Casa Sollievo della Sofferenza\" Hospital, San Giovanni Rotondo, Italy"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Manuela Caizzi",
            "author_affiliations": [
                "Ospedale Maggiore ASUITS, Trieste, Italy"
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizio Carnevale Schianca",
            "author_affiliations": [
                "Medical Oncology, Hematopoietic Stem Cells Unit, Turin Metropolitan Transplant Center, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy"
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Cea",
            "author_affiliations": [
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy",
                "University of Genoa, Genoa, Italy"
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Agostino Tafuri",
            "author_affiliations": [
                "Hematology Unit, University Hospital Sant'Andrea-Sapienza, Rome, Italy"
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Rossi",
            "author_affiliations": [
                "Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Felicetto Ferrara",
            "author_affiliations": [
                "Hematology Unit, Azienda Ospedaliera Cardarelli, Naples, Italy"
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Livio Pagano",
            "author_affiliations": [
                "Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto Massimo Lemoli",
            "author_affiliations": [
                "Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy",
                "University of Genoa, Genoa, Italy"
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-22T02:37:21",
    "is_scraped": "1"
}